Sosei Heptares' COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development |
| November 20, 2020 | November 2020 Bond Updates |
|
TOKYO and CAMBRIDGE, England, Nov. 20, 2020 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) announces a progress update for its R&D program focused on the design and development of novel drugs targeting the SARS-CoV-2 coronavirus and to treat COVID-19. The program was... |
| View more at: https://www.prnewswire.com:443/news-releases/sosei-heptares-covid-19-program-identifies-potent-broad-spectrum-anti-viral-small-molecules-for-further-development-301177877.html |
| Related News |